NCT04174170View on ClinicalTrials.gov

Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

591

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

July 25, 2023

Study Completion Date

August 15, 2023

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

Brexpiprazole

3 mg pill

DRUG

Sertraline

150 mg pill

OTHER

Placebo

Pill

DRUG

Brexpiprazole

2 mg pill

Trial Locations (1)

10010

For additional information regarding sites, contact 844-687-8522, New York

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT04174170 - Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder | Biotech Hunter | Biotech Hunter